53
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

, , , , , , , , & show all
Pages 2595-2600 | Published online: 17 May 2017

References

  • KorfelASchlegelUDiagnosis and treatment of primary CNS lymphomaNat Rev Neurol20139631732723670107
  • ShenLChenBBChenZXvXPLinGWExpression of FOXP1 and Cydin E in primary central nervous system lymphoma and its significanceChin J Hematol2012338648652 Chinese
  • HottingerAFDeAngelisLMYahalomJAbreyLESalvage whole brain radiotherapy for recurrent or refractory primary CNS lymphomaNeurology200769111178118217846417
  • VoloschinADBetenskyRWenPYHochberyFBatchelorTTopotecan as salvage therapy for relapsed or refractory primary central nervous system lymphomaJ Neurooncol200886221121517896078
  • EntingRHDemopoulosADeAngelisLMAbreyLESalvage therapy for primary CNS lymphoma with combination of rituximab and temozolomideNeurology200463590190315365145
  • ReniMZajaFMasonWTemozolomide as salvage treatment in primary brain lymphomaBr J Cancer200796686486717325700
  • PlotkinSRBetenskyRAHochbergFHTreatment of relapsed central nervous system lymphoma with high-dose methotrexateClin Cancer Res200410175643564615355887
  • RaizerJJRademakerAEvensAMPemetrexed in the treatment of relapsed/refractory primary central nervous system lymphomaCancer2012118153743374822179954
  • ZhangJPLeeEQNayakLRetrospective study of pemetrexed as salvage therapy for central nervous system lymphomaJ Neurooncol20131151717723828279
  • AbreyLEBatchelorTTFerreriAJInternational Primary CNS Lymphoma Collaborative GroupReport of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphomaJ Clin Oncol200523225034504315955902
  • DoucetSKumthekarPRaizerJPrimary central nervous system lymphomaCurr Treat Options Oncol20131418518723456261
  • BirnbaumTStadlerEABaumgartenLStraubeARituximab significantly improves complete response rate in patients with primary CNS lymphomaJ Neurooncol2012109228529122570142
  • WongSFGanHKCherLA single center study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomideJ Chin Neurosci2012191115011505
  • NayakLAbreyLEDrappatzJMulticenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLeuk Lymphoma2013541586122656234
  • ArgirisAPennellaEKoustenisAHossainAMObasajuCKPemetrexed in head and neck cancer: a systematic reviewOral Oncol201349649250123466170